Related Experiment Video

Updated: Apr 16, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K

Cdc42: Role in Cancer Management

Muhammad Imran Qadir1, Amna Parveen2, Muhammad Ali3

  • 1Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.

Chemical Biology & Drug Design
|March 18, 2015
PubMed

Insights

Cdc42, a Rho family protein, regulates crucial cell functions. Its deregulation is linked to cancer, suggesting Cdc42 inhibitors could aid tumor management.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cdc42, a Rho family GTPase, controls fundamental cellular processes like division, migration, and polarity.
  • Aberrant Cdc42 activity is implicated in various pathologies, notably cancer progression.
  • Understanding Cdc42's role is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms of Cdc42 in cancer cell progression.
  • To explore the therapeutic potential of targeting Cdc42 in cancer management.

Main Methods:

  • Literature review and analysis of existing studies on Cdc42 signaling pathways.
  • Bioinformatic analysis of Cdc42 expression in cancer datasets.
  • Exploration of potential Cdc42-targeting strategies.

Main Results:

  • Cdc42 is a key regulator of cellular transformation, invasion, and migration in cancer cells.
  • Dysregulation of Cdc42 signaling pathways contributes to tumor initiation and progression.
  • Modulating Cdc42 levels and activity shows promise in controlling tumor growth.

Conclusions:

  • Cdc42 plays a critical role in cancer cell progression at the molecular level.
  • Targeting Cdc42 offers a potential therapeutic strategy for cancer treatment.
  • Further research into Cdc42 inhibitors is warranted for effective cancer management.
Keywords:
Cdc42GTPase-activating proteinscell division control proteinguanine exchange factor

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.9K

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K